{"id":"https://openalex.org/W2016365261","doi":"https://doi.org/10.1038/sj.bjp.0705052","title":"Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2\u2010(2\u2010benzofuranyl)\u20102\u2010imidazoline in rat locus coeruleus neurons","display_name":"Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2\u2010(2\u2010benzofuranyl)\u20102\u2010imidazoline in rat locus coeruleus neurons","alternate_titles":[],"publication_year":2003,"publication_date":"2003-02-01","ids":{"openalex":"https://openalex.org/W2016365261","doi":"https://doi.org/10.1038/sj.bjp.0705052","mag":"2016365261","pmid":"https://pubmed.ncbi.nlm.nih.gov/12569074","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1573679"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0705052","doi":"https://doi.org/10.1038/sj.bjp.0705052","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705052","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705052","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016365261"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705052","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036933296","display_name":"Eduardo Ruiz\u2010Dur\u00e1ntez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eduardo Ruiz\u2010Dur\u00e1ntez","raw_affiliation_strings":["Departamento de Farmacolog\u00eda, Universidad del Pa\u00eds Vasco, E-48940 Leioa, Vizcaya, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Farmacolog\u00eda, Universidad del Pa\u00eds Vasco, E-48940 Leioa, Vizcaya, Spain","institution_ids":["https://openalex.org/I169108374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056462818","display_name":"Mar\u00eda Torrecilla","orcid":"https://orcid.org/0000-0003-0830-9988","observed_orcids":["https://orcid.org/0000-0003-0830-9988"]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda Torrecilla","raw_affiliation_strings":["Departamento de Farmacologi\u0301a, Universidad del Pai\u0301s Vasco, E-48940 Leioa, Vizcaya, Spain","Departamento de Farmacolog\u00eda, Universidad del Pa\u00eds Vasco, E-48940 Leioa, Vizcaya, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Farmacologi\u0301a, Universidad del Pai\u0301s Vasco, E-48940 Leioa, Vizcaya, Spain","institution_ids":["https://openalex.org/I169108374"]},{"raw_affiliation_string":"Departamento de Farmacolog\u00eda, Universidad del Pa\u00eds Vasco, E-48940 Leioa, Vizcaya, Spain","institution_ids":["https://openalex.org/I169108374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089302965","display_name":"Joseba Pineda","orcid":"https://orcid.org/0000-0002-9421-1081","observed_orcids":["https://orcid.org/0000-0002-9421-1081"]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Joseba Pineda","raw_affiliation_strings":["Departamento de Farmacologi\u0301a, Universidad del Pai\u0301s Vasco, E-48940 Leioa, Vizcaya, Spain","Departamento de Farmacolog\u00eda, Universidad del Pa\u00eds Vasco, E-48940 Leioa, Vizcaya, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Farmacologi\u0301a, Universidad del Pai\u0301s Vasco, E-48940 Leioa, Vizcaya, Spain","institution_ids":["https://openalex.org/I169108374"]},{"raw_affiliation_string":"Departamento de Farmacolog\u00eda, Universidad del Pa\u00eds Vasco, E-48940 Leioa, Vizcaya, Spain","institution_ids":["https://openalex.org/I169108374"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062853175","display_name":"Luisa Ugedo","orcid":"https://orcid.org/0000-0001-5993-0606","observed_orcids":["https://orcid.org/0000-0001-5993-0606"]},"institutions":[{"id":"https://openalex.org/I169108374","display_name":"University of the Basque Country","ror":"https://ror.org/000xsnr85","country_code":"ES","type":"education","lineage":["https://openalex.org/I169108374"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Luisa Ugedo","raw_affiliation_strings":["Departamento de Farmacologi\u0301a, Universidad del Pai\u0301s Vasco, E-48940 Leioa, Vizcaya, Spain","Departamento de Farmacolog\u00eda, Universidad del Pa\u00eds Vasco, E-48940 Leioa, Vizcaya, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Farmacologi\u0301a, Universidad del Pai\u0301s Vasco, E-48940 Leioa, Vizcaya, Spain","institution_ids":["https://openalex.org/I169108374"]},{"raw_affiliation_string":"Departamento de Farmacolog\u00eda, Universidad del Pa\u00eds Vasco, E-48940 Leioa, Vizcaya, Spain","institution_ids":["https://openalex.org/I169108374"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5062853175"],"corresponding_institution_ids":["https://openalex.org/I169108374"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.8017,"has_fulltext":true,"cited_by_count":38,"citation_normalized_percentile":{"value":0.62086069,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"138","issue":"3","first_page":"494","last_page":"500"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.7567999958992004,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.7567999958992004,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.17810000479221344,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imidazoline-receptors","display_name":"imidazoline receptors","score":0.9150000214576721},{"id":"https://openalex.org/keywords/morphine","display_name":"morphine","score":0.7269999980926514},{"id":"https://openalex.org/keywords/opioid-tolerance","display_name":"opioid tolerance","score":0.9020000100135803},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.6119999885559082},{"id":"https://openalex.org/keywords/locus-coeruleus-neurons","display_name":"locus coeruleus neurons","score":0.8930000066757202},{"id":"https://openalex.org/keywords/opioid-withdrawal","display_name":"opioid withdrawal","score":0.8119999766349792},{"id":"https://openalex.org/keywords/single-unit-recording","display_name":"single-unit recording","score":0.35600000619888306}],"concepts":[{"id":"https://openalex.org/C2778468602","wikidata":"https://www.wikidata.org/wiki/Q1470452","display_name":"Locus coeruleus","level":3,"score":0.9829797744750977},{"id":"https://openalex.org/C123605464","wikidata":"https://www.wikidata.org/wiki/Q1659850","display_name":"Imidazoline receptor","level":2,"score":0.8807714581489563},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.7182098627090454},{"id":"https://openalex.org/C2778399450","wikidata":"https://www.wikidata.org/wiki/Q412221","display_name":"Clonidine","level":2,"score":0.624405562877655},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.576808750629425},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.524359941482544},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5192594528198242},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4990687370300293},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.48900946974754333},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4666673541069031},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.4577241837978363},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4554365277290344},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3852228820323944},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3655073046684265},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.24865850806236267},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09511345624923706},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.05984333157539368}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007274","descriptor_name":"Injections, Intraperitoneal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008125","descriptor_name":"Locus Coeruleus","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D008125","descriptor_name":"Locus Coeruleus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008125","descriptor_name":"Locus Coeruleus","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011955","descriptor_name":"Receptors, Drug","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D013343","descriptor_name":"Styrenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054755","descriptor_name":"Imidazoline Receptors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/sj.bjp.0705052","doi":"https://doi.org/10.1038/sj.bjp.0705052","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705052","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705052","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:12569074","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12569074","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1573679","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1573679/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1038/sj.bjp.0705052","doi":"https://doi.org/10.1038/sj.bjp.0705052","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705052","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705052","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321705","display_name":"Eusko Jaurlaritza","ror":"https://ror.org/00pz2fp31"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016365261.pdf","grobid_xml":"https://content.openalex.org/works/W2016365261.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W80493394","https://openalex.org/W1564392853","https://openalex.org/W1963690154","https://openalex.org/W1968755104","https://openalex.org/W1969355139","https://openalex.org/W1981210403","https://openalex.org/W1985154629","https://openalex.org/W1991514783","https://openalex.org/W1992069226","https://openalex.org/W1992823328","https://openalex.org/W1993604566","https://openalex.org/W1998754400","https://openalex.org/W1999624667","https://openalex.org/W2000226181","https://openalex.org/W2000662320","https://openalex.org/W2017280192","https://openalex.org/W2020776311","https://openalex.org/W2032736331","https://openalex.org/W2032997748","https://openalex.org/W2035068835","https://openalex.org/W2043425461","https://openalex.org/W2048012525","https://openalex.org/W2048853229","https://openalex.org/W2054632071","https://openalex.org/W2057615993","https://openalex.org/W2067112170","https://openalex.org/W2069553305","https://openalex.org/W2082882293","https://openalex.org/W2093685285","https://openalex.org/W2100018667","https://openalex.org/W2113983630","https://openalex.org/W2123192568","https://openalex.org/W2137574047","https://openalex.org/W2163815564","https://openalex.org/W2171584675","https://openalex.org/W2214956132","https://openalex.org/W2252465426","https://openalex.org/W2268997758","https://openalex.org/W2417405725"],"related_works":["https://openalex.org/W2288761491","https://openalex.org/W120881657","https://openalex.org/W4390442354","https://openalex.org/W2093685285","https://openalex.org/W1998754400","https://openalex.org/W7010423249","https://openalex.org/W2320278463","https://openalex.org/W2223273269","https://openalex.org/W4313593892","https://openalex.org/W897327390"],"abstract_inverted_index":{"1":[0],"The":[1,199],"aim":[2],"of":[3,32,62,79,110,127,150,173,224,228,238,262],"this":[4],"study":[5],"was":[6,103,180,187],"to":[7,97,152,175,189,221,240,255],"determine":[8],"if":[9],"2-(2-benzofuranyl)-2-imidazoline":[10],"(2-BFI)":[11],"interacts":[12],"with":[13,67],"the":[14,18,33,59,71,148,171,211,215,226,236,260],"opioid":[15,212,263],"system":[16,213],"in":[17,70,158,214],"rat":[19,190],"locus":[20,63,154,177,216,229],"coeruleus,":[21],"using":[22],"single-unit":[23],"extracellular":[24],"recordings.":[25],"2":[26],"In":[27],"morphine-dependent":[28,72],"rats,":[29],"acute":[30],"administration":[31,78,126],"selective":[34],"imidazoline":[35,251],"receptor":[36],"ligands":[37],"2-BFI":[38,80,111,128,183,209,243],"(10":[39,52,81,118,129],"and":[40,45,91,95,130,135,166,210,235,265],"40":[41,131],"mg":[42,53,82,113,119,132,144],"kg(-1),":[43,54,83,114,120,133,145],"i.p.":[44,134],"100":[46,136],"micro":[47,137,185],"g,":[48,138],"i.c.v.)":[49,139],"or":[50,116],"valldemossine":[51,117,142],"i.p.)":[55,115,121,146],"did":[56],"not":[57,104,141],"modify":[58],"naloxone-induced":[60,93],"hyperactivity":[61,94,227],"coeruleus":[64,155,178,230],"neurons":[65,179,231],"compared":[66],"that":[68,203,250],"observed":[69,105],"control":[73],"group.":[74],"3":[75],"After":[76],"chronic":[77],"i.p.,":[84],"three":[85],"times":[86],"daily,":[87],"for":[88,259],"5":[89,198],"days)":[90],"morphine,":[92],"tolerance":[96,239],"morphine":[98,151,241],"were":[99,122],"attenuated.":[100],"This":[101,218],"effect":[102],"when":[106,182,242],"a":[107],"lower":[108],"dose":[109],"(1":[112],"used.":[123],"4":[124],"Acute":[125],"but":[140],"(40":[143],"diminished":[147],"potency":[149,172],"inhibit":[153,176],"neuron":[156],"activity":[157],"vivo":[159],"(ED(50)":[160],"values":[161],"increased":[162,194],"by":[163,195],"2.3,":[164],"2.9;":[165],"3.1":[167],"fold":[168],"respectively).":[169],"Similarly,":[170],"Met(5)-enkephalin":[174],"decreased":[181],"(100":[184],"M)":[186],"applied":[188],"brain":[191],"slices":[192],"(EC(50)":[193],"5.6;":[196],"P<0.05).":[197],"present":[200],"data":[201],"demonstrate":[202],"there":[204],"is":[205,244],"an":[206,222],"interaction":[207,219],"between":[208],"coeruleus.":[217],"leads":[220],"attenuation":[223],"both":[225],"during":[232],"opiate":[233],"withdrawal":[234],"development":[237],"chronically":[245],"administered.":[246],"These":[247],"results":[248],"suggest":[249],"drugs":[252],"may":[253],"prove":[254],"be":[256],"useful":[257],"agents":[258],"management":[261],"dependence":[264],"tolerance.":[266]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016365261","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
